RYSTIGGO sol inj 280 mg/2ml flac 2 ml
7680692270016
CH-69227
L04AG16
07.15.0.
1 / 3
google
Details
- Product number
- 6922701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- rozanolixizumabum 140 mg, histidinum, histidini hydrochloridum monohydricum, prolinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Rystiggo 280 mg/ 2ml, solution injectable
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
140.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 69227
- Drug name
- Rystiggo, solution injectable
- Galenic form
- LSINJ
- ATC Code
- L04AG16
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 12/02/2025
- Authorization expiration date
- 11/02/2030
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RYSTIGGO sol inj 280 mg/2ml flac 2 ml
- Description (DE)
- RYSTIGGO Inj Lös 280 mg/2ml Durchstf 2 ml
- Market launch
- 12/02/2025
- Narcotic (BTM)
- No